Page 23 - Covid-19

US work visa suspension 'unfortunate'; to have 'minimal impact' on ops: HCL

Larger rival TCS had called the move by the US government "unfortunate and unfair"

Icra sharply revises forecast, expects economy to shrink by 9.5% in FY21

It has earlier estimated a 5% contraction; Q1 may have seen 25% fall

HCL Tech to announce Q1 result today; here's what brokerages expect

HCL Tech, according to ICICI Securities, is expected to report 8 per cent quarter-on-quarter (QoQ) dip in dollar revenues to US$2339 million

Coronavirus LIVE updates: India's case count crosses one million mark

Coronavirus latest news: Total number of Covid-19 cases in India is now at 979,719. Maharashtra has 284,281 cases, Delhi 116,993, and Tamil Nadu 156,369. Stay tuned for coronavirus LIVE updates

From meal delivery to patrolling, Milagrow's new humanoid robots do it all

These robots include RoboDiCaprio, RoboJulia, RoboNano and RoboElf - which are specially designed to cater to hotels, hospitals, restaurants and corporate offices

IIT Madras-incubated start-up develops portable hospital for Covid cases

Hospital can be installed by four people in just two hours anywhere

India's Covid test eats into a fourth of an average person's monthly income

India's coronavirus test is costlier than in developed countries in terms of purchasing power as well, while private insurance coverage is shallower here

Phoenix Mills doesn't see itself returning to normalcy before FY22

Firm is readying a war chest to pay back debt or buy new properties

Fewer takers for smaller companies' shares amid the Covid-19 crisis

A total of 423 stocks declared illiquid in June quarter, up from 340 a year ago and and 223 in June 2018

Hope rally in diagnostic stocks may fizzle on disruption in OPD services

Lower surgeries and rising costs also likely to impact earnings; valuations too are rich

Covid-19 vaccine: China firm says execs got pre-test 'experimental shots'

Eight of the nearly two dozen potential vaccines in various stages of human testing worldwide are from China, the most of any country

Over 450 universities have conducted final exams or planning to do so: UGC

The status update by the higher education regulator came amid opposition by several states to conducting examinations in universities in view of the spike in Covid-19 cases

US June retail sales up 7.5% but Covid-19 dashes hopes of economic recovery

The Census Bureau reported Thursday that retail sales are 1.1% higher than their levels from a year ago

Irdai asks insurers to recognise make-shift hospitals for Covid claims

Also, if a regular hospital has set up a temporary facility for patients, it will be regarded as an extension of the hospital and cashless facility will be made available

India must become talent hub post-Covid to draw global investments: Nasscom

IT body chief says it is launching a Rs 436-crore reskilling project on PPP basis to help build digital fluencies in emerging technologies such as AI and cybersecurity

World Coronavirus Dispatch: UK sheds 650,000 jobs under Covid lockdown

China first major economy to rebound, Texas readies morgue trucks, Australia expands wage subsidy scheme and other pandemic-related news across the globe

Gadkari asks industry to join hands with govt to rescue Covid-hit economy

He suggested all stakeholders, including banks, financial institutions, infrastructure, MSMEs, agriculture and industries, to jointly create demand to address the need of liquidity in the economy

Term insurance products selling more during Covid-19 crisis: Survey

The term insurance ownership was highest across different categories of life insurance products, with 41 per cent metro respondents owning term products

Human trials of Covid-19 vaccine a milestone for Atmanirbhar Bharat: DBT

Zydus Cadila on Wednesday said it has initiated Phase 1 and 2 clinical trials of its Covid-19 vaccine candidate

Oxford University Covid-19 vaccine raises hopes with strong trial results

Blood samples taken from a group of UK volunteers given a dose of the vaccine showed that it stimulated the body to produce both antibodies and killer T-cells